Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeynep Bas

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinics in Dermatology|October 27, 2023
The Cancer Genome Atlas for uveal melanoma is predictive of patient outcomesZeynep Bas, Jane M Grant-Kels, Carol L Shields
Journal of Pediatric Ophthalmology and Strabismus|December 20, 2021
Angiography of Florid Tunica Vasculosa Lentis in Persistent Fetal VasculatureJohn E Williamson Iii, Zeynep Bas, Carol L Shields
Ophthalmic Plastic and Reconstructive Surgery|January 4, 2023
Conjunctival Melanoma in 430 Cases: Comparative Analysis of the Impact of Orbital Invasion on Tumor Recurrence, Metastasis, and DeathZeynep Bas, Philip W Dockery, Sara E Lally, et al.
Ophthalmology|November 18, 2021
Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal MelanomaMaria Chiara Gelmi, Zeynep Bas, Kabir Malkani, et al.
Ophthalmology|April 18, 2022
ReplyMaria Chiara Gelmi, Zeynep Bas, Kabir Malkani, et al.
Journal of Pediatric Ophthalmology and Strabismus|July 21, 2020
Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 PatientsLauren A Dalvin, Zeynep Bas, Sameeksha Tadepalli, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 22, 2021
Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 PatientsZeynep Bas, Lauren A Dalvin, Sameeksha Tadepalli, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 1, 2023
Effectiveness of treatment for iris melanoma: surgical versus radiotherapeutic approachesPhilip W Dockery, Joseph D DeSimone, Catherine K Liu, et al.
Eye (London, England)|February 26, 2022
Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impactCarol L Shields, Zeynep Bas, Andrea Laiton, et al.
Indian Journal of Ophthalmology|June 19, 2021
Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 casesCarol L Shields, Eileen L Mayro, Zeynep Bas, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinics in Dermatology|October 27, 2023
The Cancer Genome Atlas for uveal melanoma is predictive of patient outcomesZeynep Bas, Jane M Grant-Kels, Carol L Shields
Journal of Pediatric Ophthalmology and Strabismus|December 20, 2021
Angiography of Florid Tunica Vasculosa Lentis in Persistent Fetal VasculatureJohn E Williamson Iii, Zeynep Bas, Carol L Shields
Ophthalmic Plastic and Reconstructive Surgery|January 4, 2023
Conjunctival Melanoma in 430 Cases: Comparative Analysis of the Impact of Orbital Invasion on Tumor Recurrence, Metastasis, and DeathZeynep Bas, Philip W Dockery, Sara E Lally, et al.
Ophthalmology|November 18, 2021
Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal MelanomaMaria Chiara Gelmi, Zeynep Bas, Kabir Malkani, et al.
Ophthalmology|April 18, 2022
ReplyMaria Chiara Gelmi, Zeynep Bas, Kabir Malkani, et al.
Journal of Pediatric Ophthalmology and Strabismus|July 21, 2020
Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 PatientsLauren A Dalvin, Zeynep Bas, Sameeksha Tadepalli, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 22, 2021
Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 PatientsZeynep Bas, Lauren A Dalvin, Sameeksha Tadepalli, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 1, 2023
Effectiveness of treatment for iris melanoma: surgical versus radiotherapeutic approachesPhilip W Dockery, Joseph D DeSimone, Catherine K Liu, et al.
Eye (London, England)|February 26, 2022
Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impactCarol L Shields, Zeynep Bas, Andrea Laiton, et al.
Indian Journal of Ophthalmology|June 19, 2021
Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 casesCarol L Shields, Eileen L Mayro, Zeynep Bas, et al.
Pageof 2